Does ETANERCEPT Cause Interstitial lung disease? 1,267 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,267 reports of Interstitial lung disease have been filed in association with ETANERCEPT (ENBREL). This represents 0.4% of all adverse event reports for ETANERCEPT.
1,267
Reports of Interstitial lung disease with ETANERCEPT
0.4%
of all ETANERCEPT reports
133
Deaths
400
Hospitalizations
How Dangerous Is Interstitial lung disease From ETANERCEPT?
Of the 1,267 reports, 133 (10.5%) resulted in death, 400 (31.6%) required hospitalization, and 137 (10.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ETANERCEPT.
What Other Side Effects Does ETANERCEPT Cause?
Drug ineffective (60,367)
Rheumatoid arthritis (33,166)
Pain (31,961)
Arthralgia (27,429)
Injection site pain (24,717)
Off label use (20,178)
Fatigue (19,907)
Joint swelling (18,462)
Injection site erythema (17,736)
Condition aggravated (15,897)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ADALIMUMAB (1,250)
TOCILIZUMAB (1,229)
Which ETANERCEPT Alternatives Have Lower Interstitial lung disease Risk?
ETANERCEPT vs ETANERCEPT-SZZS
ETANERCEPT vs ETELCALCETIDE
ETANERCEPT vs ETEPLIRSEN
ETANERCEPT vs ETESEVIMAB
ETANERCEPT vs ETHACRYNIC ACID